The Current Ratio as of November 2024 (TTM) for Aceragen, Inc. (ACGN) is 0.83

According to Aceragen, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.83. This represents a change of -57.25% compared to the average of 1.95 of the last 4 quarters.

Aceragen, Inc. (ACGN) Historical Current Ratio (quarterly & annually)

How has ACGN Current Ratio performed in the past?

The mean historical Current Ratio of Aceragen, Inc. over the last ten years is 6.72. The current 0.83 Current Ratio has changed 1.14% with respect to the historical average. Over the past ten years (40 quarters), ACGN's Current Ratio was at its highest in in the March 2015 quarter at 18.76. The Current Ratio was at its lowest in in the March 2023 quarter at 0.

Aceragen, Inc. (ACGN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Aceragen, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aceragen, Inc. (ACGN) Average Current Ratio

How has ACGN Current Ratio performed in the past?

The current Current Ratio of Aceragen, Inc. (ACGN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Aceragen, Inc. (ACGN) Current Ratio vs. Peers

How is ACGN’s Current Ratio compared to its peers?

Aceragen, Inc.’s Current Ratio is less than Addex Therapeutics Ltd (4.97), greater than ERYTECH Pharma S.A. (0), less than Soligenix, Inc. (1.52), less than Avenue Therapeutics, Inc. (4.30), greater than Akari Therapeutics, Plc (0.58), greater than Armata Pharmaceuticals, Inc. (0.25), less than Anebulo Pharmaceuticals, Inc. (13.46), greater than Scopus BioPharma Inc. (0.05), less than Processa Pharmaceuticals, Inc. (3.97), less than Neoleukin Therapeutics, Inc. (15.33), less than Senti Biosciences, Inc. (4.89), less than Hillstream BioPharma, Inc. (2.25), less than SAB Biotherapeutics, Inc. (5.24), less than Quoin Pharmaceuticals, Ltd. (3.35), less than Cocrystal Pharma, Inc. (7.41), less than iBio, Inc. (4.08), less than Bio-Path Holdings, Inc. (1.67), less than Tempest Therapeutics, Inc. (2.17), less than RenovoRx, Inc. (4.39), less than Acrivon Therapeutics, Inc. Common Stock (16.16), less than Acurx Pharmaceuticals, Inc. (2.09),

Build a custom stock screener for Aceragen, Inc. (ACGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aceragen, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aceragen, Inc. (ACGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aceragen, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.